Excellent 4.6 out of 5
Plasticizers & Consumer Chemicals

Mono-2-ethylhexyl Phthalate (MEHP) Environmental Toxin Test

This urine test measures MEHP, a key marker of DEHP phthalate exposure, helping you identify and reduce contact with harmful plastics. Lowering elevated levels may help you avoid hormone disruption, fertility and developmental problems, thyroid and metabolic issues, and potential liver and cardiovascular effects.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for Mono-2-ethylhexyl Phthalate (MEHP)
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to this environmental toxin and how it compares with typical levels.
  • Identify meaningful exposure patterns and potential sources (e.g., recent contact, products, water, air, food).
  • Clarify whether this environmental toxin could be contributing to specific symptom clusters or system stress (e.g., endocrine, neuro, hepatic).
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages.
  • Track trends over time after changing products, environment, or occupational exposures.
  • If appropriate, inform conversations with your clinician about additional evaluations or targeted reduction strategies.

What is Mono-2-ethylhexyl Phthalate (MEHP)?

MEHP is a primary metabolite of DEHP, one of the most widely used phthalates that makes plastics like PVC soft and flexible. Think vinyl flooring, shower curtains, wire coatings, food processing tubing, and some medical devices. Small amounts of DEHP can migrate into food (especially fatty foods), settle into house dust, or enter the body during medical procedures that use flexible plastic components. In people, DEHP is quickly broken down to MEHP and then further transformed into secondary metabolites. Most labs measure MEHP and related metabolites in urine, often with creatinine correction, to reflect recent exposure over the prior day or two rather than long-term body burden.

Why it matters: MEHP can interact with hormone signaling (notably androgen pathways), activate receptors involved in metabolism (like PPARs), and increase oxidative stress. These biologic effects are most concerning during sensitive windows such as fetal development and early childhood, but they also matter for adults who have repeated exposures at work or at home. The body absorbs DEHP, rapidly converts it to MEHP, conjugates it (for example, via glucuronidation in the liver), and excretes it in urine. Because elimination is relatively fast, levels rise and fall with what you encounter in daily life. MEHP itself does not bioaccumulate for years the way some persistent chemicals do, but frequent exposure can keep levels elevated. Evidence includes large biomonitoring surveys and observational studies, though more research is needed to define precise risk at specific concentrations.

Why Is It Important to Test For MEHP?

MEHP sits at the crossroads of everyday products and hormone biology. In lab and human observational studies, higher phthalate metabolite levels have been linked to anti-androgenic effects (the opposite direction of testosterone’s usual actions), subtle thyroid hormone shifts, and markers of oxidative stress. Those pathways help explain why researchers study phthalates in relation to male fertility parameters, menstrual and ovarian function, pregnancy outcomes, neurodevelopment, and cardiometabolic markers. Testing provides a snapshot of recent exposure, which is often what determines short-term biologic effects. For example, eating oily takeout stored hot in soft plastic or spending a day in a newly renovated space with fresh vinyl can temporarily nudge levels up. On the other hand, a consistently elevated pattern may suggest a recurring source such as occupational contact with flexible PVC or frequent use of certain materials in the home environment.

MEHP testing helps separate incidental contact from sustained exposure. That distinction matters when you are troubleshooting real-life questions: Could a regularly used product be contributing to endocrine stress that aligns with low-energy days, changes in recovery after workouts, or shifts in menstrual cycles? Are there workplace processes that correlate with headaches by midweek? For pregnancy or fertility planning, even small differences in exposure can be relevant because fetal development is exquisitely time-sensitive. Medical settings are another unique context: flexible tubing and bags can be a temporary source of DEHP, and this has been studied in premature infants and patients needing intensive procedural care. While not every elevation is clinically significant, seeing your own data makes patterns visible so you can prioritize conversations with your clinician about whether additional evaluation is warranted. Big picture, MEHP is one piece of an environmental exposure profile. It complements other phthalate metabolites (such as oxidized DEHP metabolites), along with general health labs, symptoms, and life context. Repeated measurements over time help confirm whether a spike was a one-off or whether there is a persistent signal that deserves attention.

What Insights Will I Get From an MEHP Test?

Results are typically reported against a population reference range derived from large surveys. Because MEHP reflects recent exposure and the body clears it relatively quickly, lower values generally indicate limited near-term contact. Interpretation is strongest when you know what happened in the 24–48 hours before your test and when you use follow-up measurements to see if a pattern holds.

When levels fall toward the lower end of typical, it usually means you are not experiencing notable short-term exposure and the likelihood of acute endocrine or oxidative stress from DEHP is lower. That said, levels can fluctuate with day-to-day choices, so a single low value is best viewed as a snapshot. In pregnancy and early childhood, where biology is rapidly changing, relatively lower values are generally reassuring but should still be considered alongside other health indicators.

When values are relatively higher, it often points to recent or ongoing contact with sources like flexible vinyl, food handling equipment, or indoor dust. In that context, MEHP can serve as a proxy for potential load on liver conjugation and renal clearance pathways, with possible downstream impacts where this chemical class tends to interact — endocrine signaling, mitochondrial function, and inflammatory balance. Symptoms, if present, might be nonspecific (fatigue, headaches), and results are not diagnostic on their own. Confirming with trends, and considering related metabolites that also capture DEHP exposure, improves confidence in interpretation.

Ultimately, MEHP fits into a bigger story. Patterns across multiple environmental markers, plus general health labs and your lived experience, provide the most reliable picture of risk over time. That integrated view helps distinguish a transient spike from a persistent exposure pattern and supports smarter, safer decisions with your clinician’s guidance.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a Mono-2-ethylhexyl Phthalate (MEHP) test?

This test measures mono-2-ethylhexyl phthalate (MEHP), the primary metabolite of the plasticizer di(2‑ethylhexyl) phthalate (DEHP), serving as an exposure marker (metabolite) for DEHP contact. It is typically measured in urine to estimate recent exposure to DEHP from plastics, medical devices, and consumer products. MEHP is biologically active and has been linked in studies to endocrine-disrupting effects and potential reproductive and developmental impacts, so measured levels help assess exposure-related health risk.

Should I test for Mono-2-ethylhexyl Phthalate (MEHP)?

Testing for Mono-2-ethylhexyl Phthalate (MEHP) can be useful in specific situations because MEHP is a major urinary metabolite of DEHP, a common plasticizer; a measured level gives a snapshot of recent exposure and can help confirm whether source-reduction steps are working.

MEHP matters for health and longevity because it reflects exposure to phthalates that are linked to endocrine disruption, reproductive and developmental effects, and metabolic or thyroid perturbations; chronic or repeated exposures that alter hormones or increase inflammation may contribute to long-term disease risk and could therefore be relevant to longevity planning.

Common sources include plastics and PVC products (food packaging, tubing, vinyl flooring, some medical devices), consumer products and industrial uses; health impacts reported in the literature include effects on hormone systems, reduced sperm quality, developmental risks and possible metabolic or liver associations; testing clarifies whether someone’s internal dose is elevated, helps prioritize which exposures to target, and lets you track reductions after behavioral or environmental changes.

Who benefits most: people with high environmental or occupational exposure risk (e.g., plastics/PVC workers, people near industrial sites), parents of young children, anyone with unexplained reproductive or endocrine symptoms, those planning pregnancy or with fertility/thyroid concerns, and individuals actively optimizing detox capacity or longevity strategies.

How often should I test for Mono-2-ethylhexyl Phthalate (MEHP)?

Test once initially to establish a baseline exposure to Mono-2-ethylhexyl Phthalate (MEHP), then perform periodic follow‑up testing if baseline levels are elevated or if you have ongoing exposure risks; additionally retest after meaningful lifestyle or environmental changes — for example, “after changing household products” or “following detoxification efforts” — and whenever occupational or home exposures change.

What can affect Mono-2-ethylhexyl Phthalate (MEHP) test results?

Several factors can affect Mono-2-ethylhexyl Phthalate (MEHP) test results: timing of sample collection (phthalates are rapidly metabolized so levels vary with time since exposure); recent exposure from food, air, water, or consumer products; individual metabolism (age, genetics, liver/kidney function) which alters formation and clearance; hydration status, which can dilute or concentrate urinary measurements; and the sample type (urine versus blood), since concentrations and detection windows differ. Certain medications or dietary supplements may also influence metabolism or interfere with assays and change readings.

Are there any preparations needed before testing Mono-2-ethylhexyl Phthalate (MEHP) levels?

No fasting is usually required for MEHP testing because the metabolite is measured in urine rather than blood; most labs accept a random (spot) urine sample. A first‑morning void can reduce day‑to‑day variability and is sometimes preferred, but follow the specific instructions from the testing lab or clinician if they request a particular sample type or timing.

It is advisable, if feasible, to avoid introducing new exposures in the day or two before collection—for example avoid applying new personal care products (lotions, perfumes), handling many plastic items (food containers, receipts), or recent pesticide application—since these can influence phthalate levels. Record and report any recent product use, dietary changes, occupational or environmental contacts (plastics, personal care items, pesticides, or solvent exposures) and the timing of those contacts when you submit the sample.

How accurate is Mono-2-ethylhexyl Phthalate (MEHP) testing?

Accuracy depends strongly on sample timing, the laboratory method (e.g., mass spectrometry and validated protocols), and consistency of specimen collection and handling. Timing relative to exposure, avoidance of contamination, proper storage, use of accredited labs, and repeat or standardized sampling (versus a single random spot sample) all improve interpretability and reduce variability in measured MEHP levels.

What happens if my Mono-2-ethylhexyl Phthalate (MEHP) levels are outside the optimal or reference range?

If your Mono-2-ethylhexyl Phthalate (MEHP) level is outside the optimal or reference range, it most commonly means greater recent exposure to DEHP-containing products (for example plastics, food packaging, certain personal-care items or occupational sources) or slower clearance from your body due to metabolic or kidney/liver factors. High MEHP can be a marker of higher phthalate exposure and has been linked in some studies to potential hormone or reproductive effects, but a single result does not prove harm on its own.

Results must be interpreted in context — alongside other toxin levels, your lifestyle (diet, product use, job), medications and health markers — rather than in isolation. Your clinician may recommend reducing exposure (avoid heating food in plastics, choose phthalate-free products, increase fresh foods), re-testing, and evaluating overall health or organ function to determine whether the level reflects ongoing exposure or impaired clearance.

How do I interpret my Mono-2-ethylhexyl Phthalate (MEHP) test results?

MEHP (a primary metabolite of the plasticizer DEHP) in urine is a marker of recent exposure: higher concentration generally indicates greater recent contact with DEHP sources. Interpret results relative to the laboratory’s reference range or population percentiles, and use creatinine- or specific-gravity–adjusted values for spot urine to account for dilution. A single elevated result suggests recent exposure but does not by itself diagnose harm; clinical relevance depends on magnitude, comparison to reference values, and supporting clinical findings.

Trends are more informative than one-off measurements—repeated testing that shows rising or falling MEHP levels gives better insight into exposure changes and the effectiveness of exposure-reduction measures. Always review MEHP alongside related phthalate metabolites (other DEHP metabolites and non-DEHP phthalates) and with body-system indicators such as liver enzymes (ALT/AST), kidney function (creatinine, eGFR, urine creatinine), and oxidative-stress biomarkers (e.g., glutathione ratio, F2-isoprostanes, 8‑OHdG) because these can affect metabolism, elimination, or reflect biologic impact. Interpret results in the context of known exposures (occupational, medical devices, diet, consumer products) and discuss findings with a clinician or toxicologist to determine whether further testing, exposure mitigation, or clinical follow-up is needed.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start testing
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you